Reversible hyperinsulinemic hypoglycemia after gastric bypass: A consequence of altered nutrient delivery

Journal of Clinical Endocrinology and Metabolism

Volumn 95, Issue 4, 2010, Pages 1851-1855

  McLaughlin, Tracey ^a   Peck, Marcia ^a   Holst, Jens ^b   Deacon, Carolyn ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACARBOSE; DIAZOXIDE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; INSULIN; OCTREOTIDE;

ADULT; ARTICLE; CASE REPORT; CONTROLLED STUDY; FEMALE; GASTROINTESTINAL TRACT; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; HYPERINSULINEMIA; HYPERINSULINEMIC HYPOGLYCEMIA; HYPERTROPHY; HYPOGLYCEMIA; INSULIN RELEASE; INSULINOMA; MEAL; NUTRIENT; NUTRITIONAL STATUS; PANCREAS ISLET BETA CELL; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SMALL INTESTINE OBSTRUCTION; STOMACH BYPASS; STOMACH TUBE; BLOOD; BODY MASS; GLUCOSE BLOOD LEVEL; HYPERINSULINISM; METABOLISM; MORBID OBESITY; POSTOPERATIVE COMPLICATION; ROUX Y ANASTOMOSIS;

ADULT; ANASTOMOSIS, ROUX-EN-Y; BLOOD GLUCOSE; BODY MASS INDEX; FEMALE; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON; GLUCAGON-LIKE PEPTIDE 1; HUMANS; HYPERINSULINISM; HYPOGLYCEMIA; INSULIN; NUTRITIONAL STATUS; OBESITY, MORBID; POSTOPERATIVE COMPLICATIONS;

EID: 77951624099     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2009-1628     Document Type: Article

References (25)

1. Service GJ, Thompson GB, Service FJ, Andrews JC, Collazo-Clavell ML, Lloyd RV 2005 Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery. N Engl J Med 353:249-254
2. Patti ME, McMahon G, Mun EC, Bitton A, Holst JJ, Goldsmith J, Hanto DW, Callery M, Arky R, Nose V, Bonner-Weir S, Goldfine AB 2005 Severe hypoglycemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia. Diabetologia 48:2236-2240
3. Kim SH, Liu TC, Abbasi F, Lamendola C, Morton JM, Reaven GM, McLaughlin TL 2009 Plasma glucose and insulin regulation is abnormal following gastric bypass surgery with or without neuroglycopenia. Obes Surg 19:1550-1556
4. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, Schoelles K 2004 Bariatric surgery: a systematic review and metaanalysis. JAMA 292:1724-1737 (Pubitemid 39346675)
5. Moo TA, Rubino F 2008 Gastrointestinal surgery as treatment for type 2 diabetes. Curr Opin Endocrinol Diabetes Obes 15:153-158
6. Clements RH, Gonzalez QH, Long CI, Wittert G, Laws HL 2004 Hormonal changes after Roux-en gastric bypass for morbid obesity and the control of type-II diabetes mellitus. Am Surg 70:1-4; discussion 4-5
7. Borg CM, le Roux CW, Ghatei MA, Bloom SR, Patel AG, Aylwin SJ 2006 Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety. Br J Surg 93:210-215
8. Goldfine AB, Mun E, Patti ME 2006 Hyperinsulinemic hypoglycemia following gastric bypass surgery for obesity. Curr Opin Endocrinol Diabetes 13:419-424
9. Xu G, Stoffers DA, Habener JF, Bonner-Weir S 1999 Exendin-4 stimulates both β-cell replication and neogenesis, resulting in increased β-cell mass and improved glucose tolerance in diabetic rats. Diabetes 48:2270-2276 (Pubitemid 30395416)
10. Farilla L, Hui H, Bertolotto C, Kang E, Bulotta A, Di Mario U, Perfetti R 2002 Glucagon-like peptide-1 promotes islet cell growth and inhibits in Zucker diabetic rats. Endocrinology 143:4397-4408
11. Li Y, Hansotia T, Yusta B, Ris F, Halban PA, Drucker DJ 2003 Glucagon-like peptide-1 receptor signaling modulates β cell apoptosis. J Biol Chem 278:471-478 (Pubitemid 36043598)
12. Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R 2003 Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149-5158
13. Stoffers DA, Kieffer TJ, Hussain MA, Drucker DJ, Bonner-Weir S, Habener JF, Egan JM 2000 Insulinotropic glucagon-like peptide-1 agonists stimulate expression of homeodomain protein IDX-1 and increase β-cell mass in a mouse pancreas. Diabetes 49:741-748 (Pubitemid 30339989)
14. Meier JJ, Butler AE, Galasso R, Butler PC 2006 Hyperinsulinemic hypoglycemia after gastric bypass surgery is not accompanied by islet hyperplasia or increased β-cell turnover. Diabetes Care 29:1554-1559
15. Scavini M, Pontiroli AE, Folli F 2005 Asymptomatic hyperinsulinemic hypoglycemia after gastric banding. N Engl J Med 353:2822-2823
16. Korner J, Bessler M, Inabnet W, Taveras C, Holst JJ 2007 Exaggerated glucagon-like peptide-1 and blunted glucose-dependent insulinotropic peptide secretion are associated with Roux-en-Y gastric bypass but not adjustable gastric banding. Surg Obes Relat Dis 3:597-601
17. Yeni-Komshian H, Carantoni M, Abbasi F, Reaven GM 2000 Relationship between several surrogate estimates of insulin resistance and quantification of insulin-mediated glucose disposal in 490 healthy nondiabetic volunteers. Diabetes Care 23:171-175 (Pubitemid 30071019)
18. Orskov C, Rabenhøj L, Wettergren A, Kofod H, Holst JJ 1994 Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide-1 in humans. Diabetes 43:535-539 (Pubitemid 24096293)
19. Krarup T, Holst JJ 1984 The heterogeneity of gastric inhibitory polypeptide in porcine and human gastrointestinal mucosa evaluated with five different antisera. Regul Pept 9:35-46
20. Orskov C, Jeppesen J, Madsbad S, Holst JJ 1991 Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine. J Clin Invest 87:415-423
21. Wagner M, Dikopoulos N, Kulli C, Friess H, Büchler MW 1999 Standard surgical treatment in pancreatic cancer. Ann Oncol 10(Suppl 4):247-251
22. Reaven GM 2001 Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease: Syndrome X revisited. In: Jefferson LS, Cherrington AD, eds. Handbook of physiology, Sect. 7. The endocrine system, Vol II. The endocrine pancreas and regulation of metabolism. Oxford, UK: Oxford University Press; 1169-1197
23. Jones CN, Abbasi F, Carantoni M, Polonsky KS, Reaven GM 2000 Roles of insulin resistance and obesity in regulation of plasma insulin concentrations. Am J Physiol Endocrinol Metab 278:E501-E508
24. Holst JJ 2007 The physiology of glucagon-like peptide 1. Physiol Rev 87:1409-1439
25. Meier JJ, Deacon CF, Schmidt WE, Holst JJ, Nauck MA 2007 Suppression of glucagon secretion is lower after oral glucose administration than during intravenous glucose administration in human subjects. Diabetologia 50:806-813